Impact of solifenacin on diary-recorded and patient-reported urgency in patients with severe overactive bladder (OAB) symptoms

By Serels Scott R.   Toglia Marc R.   Forero-Schwanhaeuser Sergio   He Weizhong  

Current Medical Research and Opinion, Vol. 26, Iss. 10, 2010-10 ,pp. : 2277-2285

Informa Healthcare

Access to resources Recommend Favorite

Effect of fesoterodine 4 mg on bladder diary and patient-reported outcomes during the first week of treatment in subjects with overactive bladder

By Corcos Jacques   Angulo Javier C.   Garely Alan D.   Carlsson Martin   Gong Jason   Guan Zhonghong  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 1059-1065

Informa Healthcare

Access to resources Recommend Favorite

Solifenacin treatment for overactive bladder in black patients: patient-reported symptom bother and health-related quality of life outcomes

By Mallett Veronica   Burks David   Garely Alan D.   Smith Neila  

Current Medical Research and Opinion, Vol. 23, Iss. 4, 2007-04 ,pp. : 821-831

Informa Healthcare

Access to resources Recommend Favorite

Patient-Reported Side Effects of Intradetrusor Botulinum Toxin Type A for Idiopathic Overactive Bladder Syndrome

By  

Urologia Internationalis, Vol. 86, Iss. 1, 2010-07 ,pp. : 68-72

Karger

Access to resources Recommend Favorite

Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms*

By Herschorn Sender   Heesakkers John   Castro-Diaz David   Wang Joseph T.   Brodsky Marina   Guan Zhonghong  

Current Medical Research and Opinion, Vol. 24, Iss. 12, 2008-12 ,pp. : 3513-3521

Informa Healthcare

Access to resources Recommend Favorite